INSTITUTIONAL CLINICAL OVERVIEW JCI & NABH ACCREDITED NETWORK ISO 9001:2015 • ICMR COMPLIANT

Clinical Overview & Regenerative Excellence in India

Stem Cell Therapy Center India is the country’s premier clinical medical tourism coordination gateway. We bridge international patients from over 85 countries with accredited tertiary super-specialty hospitals, certified cGMP biotechnology cleanrooms, and renowned regenerative physicians across New Delhi NCR, Mumbai, Bangalore, and Chennai.

Immediate Medical Desk: +91-7744005984 (24/7 International Desk)
INSTITUTIONAL PROFILE
Hospital Network JCI & NABH Tertiary
Cleanroom Class ISO Class 5 / cGMP
Cell Viability > 92% Verified (AO/PI)
Ethics Compliance ICMR-DBT & IEC Oversight
Clinical Scope Adult MSCs & HSCT
International Care 85+ Global Countries
Consult Medical Board →
20+
Years Clinical Heritage
2,500+
Global Patient Journeys
100+
Chronic Conditions
4 Hubs
Delhi • Mumbai • BLR • MAA
MD

Clinical Oversight & Facility Verification

E-E-A-T Verified

All patient guidance, clinical protocols, and cell handling benchmarks comply strictly with the Indian Council of Medical Research (ICMR-DBT) and International Society for Cellular Therapy (ISCT) standards.

Last Audited: March 2026 View Editorial Policy →
Ethical Governance: Cellular treatments are facilitated exclusively through tertiary hospitals accredited by JCI and NABH, equipped with certified ISO cleanroom isolation suites, and approved under Institutional Ethics Committee (IEC) review.

Pioneering Regenerative Healthcare in India

Over the past two decades, India has emerged as a preeminent global hub for advanced medical care. Combining world-class tertiary hospitals accredited by the Joint Commission International (JCI) and the National Accreditation Board for Hospitals & Healthcare Providers (NABH) with cutting-edge biotechnology cleanrooms, India provides advanced cellular therapy solutions at an accessible price point—typically 65% to 75% less than identical therapies in the US, UK, or Europe.

Stem Cell Therapy Center India operates as a specialized international medical coordination network. Rather than operating out of solitary standalone clinics, we partner exclusively with verified academic medical institutions, university hospitals, and superspecialty centers in New Delhi NCR, Mumbai, Bangalore, and Chennai. Every international patient receives individualized multidisciplinary review, ethical cell processing, and dedicated bilingual care coordination.

Tertiary Hospital Infrastructure

All procedures occur within JCI/NABH-certified inpatient facilities with full emergency, ICU, neuro-monitoring, and surgical theaters.

cGMP Cleanroom Laboratories

State-of-the-art ISO Class 5 laminar airflow processing suites ensuring verified >90% cell viability with flow cytometry characterization.

Multidisciplinary Medical Boards

Every treatment protocol is reviewed by senior hematologists, clinical neurologists, orthopedic surgeons, and physiatrists.

Global Concierge & Triage

Complete cross-border logistics: priority medical visa invitations, airport chauffeur transfers, native language translators, and follow-up.

Statutory Framework & Ethical Standards

Cellular medicine requires stringent regulatory compliance to guarantee patient safety. In accordance with the National Guidelines for Stem Cell Research formulated jointly by the Indian Council of Medical Research (ICMR) and Department of Biotechnology (DBT), our partner institutions strictly operate under defined ethical frameworks:

ICMR • DBT National Guidelines Alignment

Full compliance with India's clinical research standards for cellular handling, ethics board clearance, and patient informed consent.

JCI • NABH Inpatient Hospital Accreditations

Partner hospitals adhere to international patient safety goals (IPSG), strict infection control, and continuous peer audit.

ISO 9001:2015 Quality Management Systems

Standardized operational protocols governing patient documentation, cell cryopreservation, logistics, and traceability.

IEC • IC-SCR Institutional Ethics Committee

All investigational cellular therapies are reviewed by independent ethics committees with active patient tracking registers.

Absolute Ethical Commitment: We strictly prohibit and do not use embryonic stem cells or aborted fetal tissues. Only ethical, non-embryonic autologous stem cells (bone marrow and adipose derived) and certified umbilical cord Wharton's Jelly mesenchymal stem cells from pre-screened healthy donor births are utilized.

Four Premier Clinical Hospital Hubs Across India

To ensure optimal clinical outcomes and geographical convenience for international arrivals, our network spans four premier healthcare hubs:

New Delhi NCR Hub

Capital Region

Direct international connectivity via Indira Gandhi International Airport (DEL). Hub of super-specialty neuro-care, bone marrow transplant suites, and comprehensive physical rehabilitation.

Mumbai Hub

Western Hub

Renowned centers for pediatric neurology, specialized cerebral palsy rehabilitation, developmental delay therapy, and advanced orthopedic cartilage repair.

Bangalore Hub

Biotech Capital

India’s biotechnology heartland with advanced cGMP cell expansion laboratories, genomic characterization suites, and stroke neuro-rehabilitation centers.

Chennai Hub

Southern Center

Asia's acclaimed clinical hematology center with extensive experience hosting medical travelers from the Middle East, East Africa, and Southeast Asia.

Want to explore our physical hospital and laboratory infrastructure? Tour Hospital Facilities →

5-Stage Laboratory Quality Assurance Standards

Cellular safety and efficacy depend entirely on laboratory isolation and culturing precision. Our partner laboratories follow a stringent 5-stage quality control process before any stem cell unit is released for clinical administration:

1. Flow Cytometry Surface Marker Verification CD73+ / CD90+ / CD105+

Immunophenotypic characterization confirming mesenchymal stem cell purity while verifying total absence of hematopoietic contaminants (CD34-, CD45-, HLA-DR-).

2. Automated 14-Day Microbial Sterility Screening 100% Sterile Release

Automated blood culture incubation screening for aerobic bacteria, anaerobic bacteria, and fungal contaminants prior to batch sign-off.

3. Endotoxin & Mycoplasma Safety Assays < 0.25 EU/ml (LAL Test)

Turbidimetric Limulus Amebocyte Lysate (LAL) testing ensuring endotoxin concentrations stay far below international pharmacopeia limits.

4. AO/PI Fluorescence Cell Count & Viability > 92% Living Cells

Acridine orange / propidium iodide automated dual-fluorescence imaging measuring exact live-to-dead cell ratios before infusion.

5. Certified Certificate of Analysis (COA) Patient Discharge Dossier

A comprehensive batch-specific lab report is handed directly to the patient and attending clinical team documenting all test results.

Partner Laboratory Virtual Tour

Patient Reception and Consultation Lounge
Reception & Consultation Lounge
cGMP Cleanroom Corridor
cGMP Cleanroom Corridor
cGMP Cleanroom Processing Suite
cGMP Processing Suite
Cell Processing and Pipetting Station
Cell Processing Station

Evidence-Based Treatment Spectrum

We maintain rigorous clinical transparency by clearly categorizing established standard-of-care treatments from investigational regenerative protocols:

Standard Indications

Hematopoietic Stem Cell Transplant (HSCT)

Proven curative hematological protocols for leukemia, lymphoma, multiple myeloma, aplastic anemia, thalassemia major, and sickle cell anemia in sterile bone marrow transplant suites.

Investigational Protocols

Mesenchymal Stem Cell (MSC) Therapies

Targeted paracrine, anti-inflammatory, and trophic tissue repair protocols for degenerative neurological, autoimmune, organ failure, and orthopedic indications under ethics oversight.

Conditions Facilitated by Medical Category

Neurological & Brain Health
Motor neuron disease, ischemic brain injury, neurodegenerative disorders:
Organ & Metabolic Regeneration
Microvascular repair and chronic inflammatory tissue remodeling:
Orthopedic & Autoimmune
Joint preservation, cartilage regeneration, immune modulation:
Vision & Cellular Immunotherapy
Microcirculation improvement and cell therapy:

How International Patients Travel to India

Traveling across the world for medical care requires meticulous coordination. Our dedicated international desk handles every logistical and clinical phase:

1

Free Diagnostic Assessment & Opinion

Submit medical history and MRI/blood reports. Senior specialists evaluate eligibility and provide a written medical opinion with cost within 24 hours.

2

Medical Visa Support & Pre-Trip Planning

Our hospital desk issues official Medical Visa (MED) invitation letters for the patient and companion to guarantee seamless Indian embassy processing.

3

Airport Chauffeur & Inpatient Suite Admission

Complimentary VIP airport pickup. Check-in to private deluxe hospital suites with companion stay, local SIM, and dedicated bilingual translator.

4

Targeted Cellular Administration & Rehab

Pre-infusion clinical workup, minimally invasive cellular delivery (intrathecal, intravenous, or intra-articular), accompanied by daily physiatry.

5

Discharge Dossier & Post-Care Tele-Consultation

Receive full Certificate of Analysis, rehabilitation protocols, home exercises, and scheduled 3, 6, and 12-month follow-up reviews via WhatsApp and video call.

Meet Our Medical Team

Qualifications, fellowships, and clinical experience of our 25+ regenerative medicine specialists.

View Medical Team →

Mission & Clinical Vision

Our institutional philosophy, ethical governance, and patient-first commitment to healing.

Read Mission & Vision →

Cost & Savings Guide

Transparent breakdown of package costs, inclusions, companion stay, and 70% cost savings compared to the West.

Explore Treatment Costs →

Patient Success Stories

Watch video testimonials and read verified recovery journeys from patients from 85+ nations.

Watch Patient Testimonials →

CLINICAL TRUST & ACCREDITATION

Verified
  • ✓
    Accreditations: JCI / NABH Inpatient Tertiary Hospitals • ISO Class 5 Cleanrooms
  • ✓
    Statutory Oversight: Institutional Committee for Stem Cell Research (IC-SCR) & Registered IEC
  • ✓
    Regulatory Alignment: Conducted under the ICMR-DBT National Guidelines for Stem Cell Research
  • ✓
Direct Inquiry

Consult Our Medical Board

Speak with our clinical coordinators regarding treatment eligibility and partner hospital centers.

100% Confidential • Response in 24h
Accredited Regional Centers
Delhi NCR (DEL) JCI • NABH
Mumbai (BOM) JCI • NABH
Bangalore (BLR) JCI • NABH
Chennai (MAA) JCI • NABH